Related Experiment Video
Updated: Aug 12, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
[Percutaneous mitral valvuloplasty with Inoue balloon and pregnancy]
C A Iñigo Riesgo1, C J Solórzano Martín, G Delgado Caro
1Hospital Gineco, Centro Médico Nacional de Occidente (CMNO) del Instituto Mexicano del Seguro Social (IMSS) en Guadalajara Jalisco, México.
Ginecologia Y Obstetricia De Mexico
|November 21, 1998
Summary
Percutaneous mitral valvuloplasty using the Inoue balloon safely treated severe mitral stenosis in pregnant women unresponsive to standard care. This intervention significantly improved maternal symptoms and hemodynamics with excellent fetal outcomes.
Area of Science:
- Interventional Cardiology
- Maternal-Fetal Medicine
- Cardiovascular Surgery
Context:
- Severe mitral stenosis in pregnancy poses significant risks to both mother and fetus.
- Conventional management is often insufficient for advanced stages (NYHA III-IV) of mitral stenosis during gestation.
- Interventional cardiology offers a less invasive alternative for managing complex cardiac conditions in pregnant patients.
Purpose:
- To evaluate the safety and efficacy of percutaneous mitral valvuloplasty (PMV) with the Inoue balloon in pregnant women with severe mitral stenosis.
- To assess the impact of PMV on maternal hemodynamics, clinical status, and pregnancy outcomes.
- To determine the safety profile for fetal exposure to the procedure and its potential complications.
Summary:
- Seven pregnant women with severe mitral stenosis underwent Inoue balloon valvuloplasty, with most procedures performed before 30 weeks gestation.
- The intervention significantly reduced mitral gradient and increased valvular area, improving pulmonary hypertension and maternal NYHA class.
- Maternal and fetal outcomes were favorable, with no mortality, minimal procedural complications, and most pregnancies reaching term.
Impact:
- Percutaneous mitral valvuloplasty with the Inoue balloon is a safe and effective treatment for severe mitral stenosis in pregnant women.
- The procedure offers significant clinical improvement and hemodynamic benefits without increasing maternal or fetal mortality.
- This technique provides a valuable therapeutic option, improving quality of life and pregnancy outcomes for this high-risk patient group.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...